IHH Healthcare Bhd (XKLS:5225) Notes Receivable: RM0 Mil (As of Mar. 2026)


XKLS:5225 IHH Healthcare Bhd XKLS:5225
88 GF Score
Price RM8.38
GF Value RM8.10
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is IHH Healthcare Bhd Notes Receivable?

IHH Healthcare Bhd XKLS:5225 +0.60% 88 Notes Receivable is RM0 Mil as of Mar. 2026. GuruFocus rates XKLS:5225 with a GF Score™ of 88/100 and a GF Value™ of RM8.10 (Fairly Valued). The stock has 7 warning signs investors should review.

IHH Healthcare Bhd's Notes Receivable for the quarter that ended in Mar. 2026 was RM0 Mil.


IHH Healthcare Bhd Notes Receivable Related Terms


IHH Healthcare Bhd Notes Receivable Historical Data

* Premium members only.

The historical data trend for IHH Healthcare Bhd's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IHH Healthcare Bhd Notes Receivable Chart

IHH Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IHH Healthcare Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:5225
88GF Score
IHH Healthcare Bhd XKLS:5225
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IHH Healthcare Bhd Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of RM0 Mil mean?
IHH Healthcare Bhd (XKLS:5225) has a Notes Receivable of RM0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on IHH Healthcare Bhd and its competitors.
Is IHH Healthcare Bhd's Notes Receivable too high?
IHH Healthcare Bhd's current Notes Receivable is RM0 Mil. Overall, IHH Healthcare Bhd has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's Notes Receivable compare to HCA and THC?
IHH Healthcare Bhd's Notes Receivable of RM0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on IHH Healthcare Bhd and its competitors. IHH Healthcare Bhd's current Notes Receivable is RM0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.10, compared to a current price of RM8.38 — trading 3.5% above its estimated fair value. The current Notes Receivable is RM0 Mil. IHH Healthcare Bhd's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current Notes Receivable is RM0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?

Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued. The current stock price of RM8.38 is trading 3.5% above its estimated GF Value™ of RM8.10. GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.

Key valuation signals for XKLS:5225:

  • Notes Receivable: RM0 Mil
  • GF Value™: RM8.10 vs. price of RM8.38 (3.5% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IHH Healthcare Bhd Business Description

Other Exchanges IHHHF:USAQ0F:Singapore
Address 3 Jalan Bangsar, Level 35, Mercu Aspire, KL Eco City, Wilayah Persekutuan, Kuala Lumpur, MYS, 59200
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
88GF Score

Get the complete analysis for XKLS:5225

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM8.38
Price
RM8.10
GF Value